News
Independent validation of our cancer drugs
A recent publication in Inorganic Chemistry uses computational tools to validate the TypeI/TypeII dual mode activity in our cancer drugs. See our press release for more details.
A recent publication in Inorganic Chemistry uses computational tools to validate the TypeI/TypeII dual mode activity in our cancer drugs. See our press release for more details.
